About the Study

Are living with anxiety, panic, or fear?

This study is designed to evaluate the efficacy of flexible doses of SEP-363856 compared with placebo in subjects with Generalized Anxiety Disorder. This study is sponsored by Sunovion Pharmaceuticals Inc.

Length of Study:  8 weeks of treatment, plus 1 week follow up.

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 65 years old
• are experiencing anxiety symptoms
• meet DSM-5 criteria for Generalized Anxiety Disorder (GAD)

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. 

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.